• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

育龄期女性的卵巢生殖细胞肿瘤:保留生育功能及预后

Germinal ovarian tumors in reproductive age women: Fertility-sparing and outcome.

作者信息

Dellino Miriam, Silvestris Erica, Loizzi Vera, Paradiso Angelo, Loiacono Rosalia, Minoia Carla, Daniele Antonella, Cormio Gennaro

机构信息

Gynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Department of Biomedical Sciences and Human Oncology, Unit of Obstetrics and Gynaecology.

出版信息

Medicine (Baltimore). 2020 Sep 25;99(39):e22146. doi: 10.1097/MD.0000000000022146.

DOI:10.1097/MD.0000000000022146
PMID:32991408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7523774/
Abstract

MOGCTs (malignant ovarian germ cell tumors) are rare tumors that mainly affect patients of reproductive age. The aim of this study was to evaluate the fertility and survival outcomes in young women with MOCGTs treated with fertility-sparing surgery (FSS).From 2000 to 2018, data from 28 patients of reproductive age with a diagnosis of MOGCT at the University of Bari were collected. Most received FSS, and in patients treated conservatively, the reproductive outcome and survival were investigated. Data of patient demographics, clinical presentation, oncology marker dosage, staging, type of surgery, histological examination, survival, and reproductive outcome were collected from hospital and office charts. All informed consent was obtained from all patients. The median age was 24 (range: 9-45 years). The majority of the patients had stage IIIC. Twenty-four woman received FSS consisting of unilateral ovariectomy and omentectomy, whereas only 4 women, based on their stage (IIIC), received a radical surgery (hysterectomy with bilateral adnexectomy, lymphadenectomy, and omentectomy). Our study shows that FSS in MOGCTs can produce good results both on reproductive outcomes and on survival. Indeed, in our group, there was only 1 case of exitus as result of recurrence. Furthermore, patients after FSS maintained normal ovarian function and 5 of 5 women who tried to get pregnant succeeded spontaneously. The median follow-up was 90 months (range 3-159).Conservative surgery for MOGCTs should be considered for women of reproductive age who wish to preserve fertility.

摘要

恶性卵巢生殖细胞肿瘤(MOGCTs)是一种罕见的肿瘤,主要影响育龄患者。本研究的目的是评估接受保留生育功能手术(FSS)治疗的年轻MOGCTs女性患者的生育能力和生存结果。2000年至2018年,收集了巴里大学28例诊断为MOGCTs的育龄患者的数据。大多数患者接受了FSS,对接受保守治疗的患者的生殖结局和生存情况进行了调查。从医院和办公室病历中收集了患者人口统计学、临床表现、肿瘤标志物剂量、分期、手术类型、组织学检查、生存情况和生殖结局的数据。所有患者均获得了知情同意。中位年龄为24岁(范围:9 - 45岁)。大多数患者为IIIC期。24名女性接受了包括单侧卵巢切除术和大网膜切除术的FSS,而只有4名女性根据其分期(IIIC期)接受了根治性手术(子宫全切术加双侧附件切除术、淋巴结切除术和大网膜切除术)。我们的研究表明,MOGCTs的FSS在生殖结局和生存方面都能产生良好的结果。事实上,在我们的研究组中,只有1例因复发而死亡。此外,接受FSS后的患者卵巢功能保持正常,5名尝试怀孕的女性中有5名自然受孕成功。中位随访时间为90个月(范围3 - 159个月)。对于希望保留生育功能的育龄女性,应考虑对MOGCTs进行保守手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/164f/7523774/7bd383a7752c/medi-99-e22146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/164f/7523774/7bd383a7752c/medi-99-e22146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/164f/7523774/7bd383a7752c/medi-99-e22146-g003.jpg

相似文献

1
Germinal ovarian tumors in reproductive age women: Fertility-sparing and outcome.育龄期女性的卵巢生殖细胞肿瘤:保留生育功能及预后
Medicine (Baltimore). 2020 Sep 25;99(39):e22146. doi: 10.1097/MD.0000000000022146.
2
Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.保留生育功能手术应成为恶性卵巢生殖细胞肿瘤患者的标准治疗方法。
J Adolesc Young Adult Oncol. 2017 Jun;6(2):270-276. doi: 10.1089/jayao.2016.0086. Epub 2017 Jan 13.
3
Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.保留生育功能手术治疗恶性卵巢生殖细胞肿瘤:来自一家三级转诊中心的 10 年临床经验。
Arch Gynecol Obstet. 2020 May;301(5):1227-1233. doi: 10.1007/s00404-020-05522-5. Epub 2020 Apr 6.
4
Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.I 期上皮性卵巢癌患者的肿瘤生育学:保留生育功能手术治疗育龄期年轻女性。
World J Surg Oncol. 2017 Aug 15;15(1):154. doi: 10.1186/s12957-017-1222-4.
5
Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.晚期恶性卵巢生殖细胞肿瘤的保留生育功能手术:一例报告
J Med Case Rep. 2017 Dec 17;11(1):350. doi: 10.1186/s13256-017-1516-8.
6
Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study.瑞典行保留生育功能手术治疗交界性卵巢肿瘤的适龄妇女生育和产科结局及总生存情况:一项前瞻性全国基于人群的研究。
Fertil Steril. 2021 Jan;115(1):157-163. doi: 10.1016/j.fertnstert.2020.07.043. Epub 2020 Sep 22.
7
Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.保留生育功能的恶性卵巢生殖细胞肿瘤治疗方法-肿瘤学和产科结局:一项回顾性研究。
Int J Gynaecol Obstet. 2024 Mar;164(3):1074-1079. doi: 10.1002/ijgo.15141. Epub 2023 Sep 22.
8
A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women.一项针对年轻女性早期上皮性卵巢癌行保留生育功能手术的肿瘤学和生殖结局的瑞典全国前瞻性研究。
BMC Cancer. 2020 Oct 19;20(1):1009. doi: 10.1186/s12885-020-07511-y.
9
Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.恶性卵巢生殖细胞肿瘤保留生育功能手术后的结局及预后因素分析
Gynecol Oncol. 2017 Jun;145(3):513-518. doi: 10.1016/j.ygyno.2017.03.023. Epub 2017 Mar 31.
10
Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial Ovarian Carcinoma: A Multicenter Retrospective Study.早期上皮性卵巢癌患者保留生育功能手术的肿瘤学和生殖结局:一项多中心回顾性研究。
Curr Med Sci. 2020 Aug;40(4):745-752. doi: 10.1007/s11596-020-2239-4. Epub 2020 Aug 29.

引用本文的文献

1
A case report of adenomyosis-induced spontaneous rupture in an unscarred and unpregnant uterus.一例未受过瘢痕损伤且未孕子宫因子宫腺肌病导致自发性破裂的病例报告。
Medicine (Baltimore). 2024 Dec 20;103(51):e41037. doi: 10.1097/MD.0000000000041037.
2
Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer.非上皮性卵巢癌保留生育功能治疗后的产科结局
Cancers (Basel). 2023 Aug 18;15(16):4170. doi: 10.3390/cancers15164170.
3
A Multi-Institutional Informed Consent Proposal as a Prevention Tool for Combined Oral Contraceptive Intake and Thrombotic Risk.

本文引用的文献

1
Malignant Mixed Germ Cell Tumors of the Ovary: A Series of Rare Cases.卵巢恶性混合性生殖细胞肿瘤:一组罕见病例
J Reprod Infertil. 2019 Oct-Dec;20(4):231-236.
2
Methods of Treatment and Outcome for Ovarian Germ Cell Tumors.卵巢生殖细胞肿瘤的治疗方法及结果
Indian J Surg Oncol. 2019 Dec;10(4):640-642. doi: 10.1007/s13193-019-00960-3. Epub 2019 Aug 13.
3
In Vitro Generation of Oocytes from Ovarian Stem Cells (OSCs): In Search of Major Evidence.从卵巢干细胞(OSCs)体外生成卵子:寻找主要证据。
一项多机构知情同意书提案,作为联合口服避孕药摄入与血栓形成风险的预防工具。
J Pers Med. 2023 Mar 27;13(4):584. doi: 10.3390/jpm13040584.
4
Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.BRCA1 相互作用蛋白 C 端解旋酶 1(BRIP1)在人类肿瘤中的多分子特征和作用:泛癌分析。
World J Surg Oncol. 2023 Mar 13;21(1):91. doi: 10.1186/s12957-022-02877-8.
5
Hormone replacement therapy in BRCA mutation carriers: how shall we do no harm?BRCA 突变携带者的激素替代疗法:我们如何做到不造成伤害?
Hormones (Athens). 2023 Mar;22(1):19-23. doi: 10.1007/s42000-022-00427-1. Epub 2023 Jan 13.
6
SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study.SARS-CoV-2 疫苗与妇产科不良事件:意大利首项回顾性研究。
Int J Environ Res Public Health. 2022 Oct 13;19(20):13167. doi: 10.3390/ijerph192013167.
7
Lactobacillus crispatus M247 oral administration: Is it really an effective strategy in the management of papillomavirus-infected women?卷曲乳杆菌M247口服给药:它真的是治疗乳头瘤病毒感染女性的有效策略吗?
Infect Agent Cancer. 2022 Oct 21;17(1):53. doi: 10.1186/s13027-022-00465-9.
8
Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case-Control Analysis.口服肌醇和D-手性肌醇对淋巴瘤女性长期幸存者卵巢功能的影响:一项前瞻性病例对照分析的结果
J Pers Med. 2022 Sep 19;12(9):1536. doi: 10.3390/jpm12091536.
9
Communications Is Time for Care: An Italian Monocentric Survey on Human Papillomavirus (HPV) Risk Information as Part of Cervical Cancer Screening.沟通即关怀时刻:一项关于人乳头瘤病毒(HPV)风险信息的意大利单中心调查,作为宫颈癌筛查的一部分
J Pers Med. 2022 Aug 26;12(9):1387. doi: 10.3390/jpm12091387.
10
Uterine rupture after previous caesarean section with hysterotomy above the lower uterine segment.剖宫产后子宫下段上方子宫切开术后子宫破裂。
Acta Biomed. 2022 Sep 21;93(S1):e2022269. doi: 10.23750/abm.v93iS1.12872.
Int J Mol Sci. 2019 Dec 10;20(24):6225. doi: 10.3390/ijms20246225.
4
Fertility-sparing surgery for treatment of non-epithelial ovarian cancer: Oncological and reproductive outcomes in a prospective nationwide population-based cohort study.保留生育功能手术治疗非上皮性卵巢癌:一项前瞻性全国基于人群队列研究的肿瘤学和生殖结局。
Gynecol Oncol. 2019 Nov;155(2):287-293. doi: 10.1016/j.ygyno.2019.08.017. Epub 2019 Sep 4.
5
Preservation of fertility in patients with cancer (Review).癌症患者的生育力保存(综述)。
Oncol Rep. 2019 May;41(5):2607-2614. doi: 10.3892/or.2019.7063. Epub 2019 Mar 14.
6
Fertility preservation in ovarian tumours.卵巢肿瘤中的生育力保存
Ecancermedicalscience. 2018 Dec 6;12:885. doi: 10.3332/ecancer.2018.885. eCollection 2018.
7
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms.卵巢肿瘤保留生育功能手术和化疗后卵巢功能、生育力和绝经发生情况。
Gynecol Oncol. 2019 Feb;152(2):346-352. doi: 10.1016/j.ygyno.2018.11.032. Epub 2018 Dec 18.
8
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update Summary.癌症患者的生育力保存:美国临床肿瘤学会临床实践指南更新摘要
J Oncol Pract. 2018 Jun;14(6):381-385. doi: 10.1200/JOP.18.00160. Epub 2018 May 16.
9
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.非上皮性卵巢癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv1-iv18. doi: 10.1093/annonc/mdy001.
10
Ovarian dysgerminoma in pregnancy: A case report and literature review.妊娠性卵巢未成熟畸胎瘤:病例报告及文献复习。
Cancer Biol Ther. 2018 Aug 3;19(8):649-658. doi: 10.1080/15384047.2018.1450118. Epub 2018 Apr 25.